The regulation of ribonucleoside diphosphate reductase by the tumor promoter orotic acid in normal rat liver in vivo

Molecular Carcinogenesis

Volumn 24, Issue 3, 1999, Pages 188-196

  Manjeshwar, Sharmila ^a,b   Rao, Prema M ^a   Rajalakshmi, Srinivasan ^a   Sarma, Dittakavi S R ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Liver tumor promotion; Mitoinhibition; Orotic acid; Ribonucleoside diphosphate reductase

Indexed keywords

OROTIC ACID; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME REGULATION; LIVER TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA TRANSCRIPTION;

ANIMALIA;

EID: 0032899371     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2744(199903)24:3<188::aid-mc5>3.0.co;2-%23     Document Type: Article

References (55)

1. Rao PM, Nagamine Y, Ho RK, et al. Dietary orotic acid enhances the incidence of γ-glutamyltranspeptidase positive foci in rat liver induced by chemical carcinogens. Carcinogenesis 1983;4:1541-1545.
2. Laurier C, Tatematsu M, Rao PM, Rajalakshmi S, Sarma DSR. Promotion by orotic acid of liver carcinogenesis in rats initiated by 1,2-dimethylhydrazine. Cancer Res 1984;44:2186-2191.
3. Bradley G, Sharma RK, Rajalakshmi S, Ling V. P-Glycoprotein expression during tumor progression in the rat liver. Cancer Res 1992;52:5154-5161.
4. Rao PM, Laconi E, Rajalakshmi S, Sarma DSR. Orotic acid, a liver tumor promoter, also promotes carcinogenesis of the intestine. Abstract. Proceedings of the American Association for Cancer Research 1986;27:142.
5. Elliot TS, Visek WJ. Effects of orotic acid feeding on carcinogenesis. FASEB J 1989;3:A474.
6. Kokkinakis DM, Scarpelli DG, Oyasu R. Enhancement of N-nitroso (2-hydroxypropyl)(2-oxypropyl) amine induced tumorigenesis in Sprague-Dawley rats by orotic acid. Carcinogenesis 1991;12:181-186.
7. Laconi E, Li F, Semple E, Rao PM, Rajalakshmi S, Sarma DSR. Inhibition of DNA synthesis in primary cultures of hepatocytes by orotic acid. Carcinogenesis 1988;9:675-677.
8. Pichiri-Coni G, Coni P, Laconi E, et al. Studies on the mitoinhibitory effect of orotic acid on hepatocytes in primary culture. Carcinogenesis 1990;11:981-984.
9. Manjeshwar S, Sheikh A, Pichiri-Coni G, et al. Orotic acid, nucleotide imbalance and liver tumor promotion: A possible mechanism for the mitoinhibitory effects of orotic acid in isolated rat hepatocytes. Cancer Res 1992;52:2078s-2081s.
10. Sheikh A, Yusuf A, Laconi E, Rao PM, Rajalakshmi S, Sarma DSR. Effect of orotic acid on in vivo DNA synthesis in hepatocytes of normal rat liver and in hepatic foci/nodules. Carcinogenesis 1993;14:907-912.
11. Backway KL, Laconi E, Manjeshwar S, Rao PM, Rajalakshmi S, Sarma DSR. Resistance of hepatic nodules to orotic acid induced accumulation of uridine nucleotides. Carcinogenesis 1994;15:403-406.
12. Rajalakshmi S, Sarma DSR, Sarma PS. Studies on orotic acid fatty liver. Biochem J 1961;80:375-378.
13. Lea MA, Luke A, Assad A, Ayyala S. Inhibitory effects of orotate on precursor incorporation into nucleic acids. Chem Biol Interact 1990;75:49-59.
14. Murphee S, Moore EC, Beall PT. Regulation by nucleotides of the activity of partially purified ribonucleotide reductases from rat embryos. Cancer Res 1968;28:860-863.
15. Moore EC, Hulbert RB. Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors. J Biol Chem 1966;241:4802-4809.
16. Thelander L, Eriksson S, Akerman M. Ribonucleotide reductase from calf thymus: Separation of the enzyme into two non-identical subunits, protein M1 and M2. J Biol Chem 1980;255:7426-7432.
17. Nutter LM, Cheng YC. Nature and properties of mammalian ribonucleoside diphosphate reductase. In: Cory JG, Cory AH, editors. Inhibitors of ribonucleoside diphosphate reductase activity. New York: Pergamon Press; 1989. p 37-54.
18. Turner MK, Abrams R, Lieberman I. Levels of ribonucleotide reductase activity during the division cycle of the L cell. J Biol Chem 1968;243:3725-3728.
19. Murphee S, Stubblefield E, Moore EC. Synchronized mammalian cultures. Exp Cell Res 1969;58:118-124.
20. Larsson A. Ribonucleotide reductase from regenerating rat liver. Eur J Biochem 1969;11:113-121.
21. Cory JG, Fleisher AE. Non-coordinate changes in the components of ribonucleotide reductase in mammalian cells. J Biol Chem 1982;257:1263-1266.
22. Elford HL, Freese M, Passamani E, Morris HP. Ribonucleotide reductase and cell proliferation 1. Variations of ribonucleotide reductase activity with tumor growth in a series of rat hepatomas. J Biol Chem 1970;245:5228-5233.
23. King CD, Van Lancker JL. Molecular mechanisms of liver regeneration. VII. Conversion of cytidine to deoxycytidine in regenerating rat livers. Arch Biochem Biophys 1969;129:603-608.
24. Youdale T, Frappier L, Whitfield JF, Rixon RA. Changes in the cytoplasmic and nuclear activities of the ribonucleotide reductase holoenzyme and its subunits in regenerating liver cells in normal and thyroparathyroidectomized rats. Canadian Journal of Biochemistry and Cell Biology 1984;62:914-919.
25. Steeper JR, Steuart CD. A rapid assay for CDP reductase in mammalian cell extracts. Anal Biochem 1970;34:123-130.
26. Takeda E, Weber G. Role of ribonucleotide reductase in expression of the neoplastic program. Life Sci 1981;28:1007-1014.
27. Youdale T, MacManus JP. Separation of a subunit necessary for CDP reductase from other ribonucleotide reductase activities of regenerating rat liver. Biochem Biophys Res Comm 1979;89:403-409.
28. Payne SM, Ames BN. A procedure for rapid extraction and high pressure liquid chromatography separation of nucleosides and other small molecules from bacterial cells. Anal Biochem 1982;123:151-161.
29. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970;227:680-685.
30. Chirgwin JM, Przlyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
31. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1982. p 97-199.
32. Manjeshwar S, Pichiri-Coni G, Coni P, Rao PM, Rajalakshmi S, Sarma DSR. Ribonucleotide reductase: A possible target for orotic acid induced mitoinhibition in normal hepatocytes in primary culture. Cancer Lett 1993;73:149-154.
33. Schibler U, Hagenbuchle O, Wellauer PK, Pittet AC. Two promoters of different strengths control the transcription of the mouse a-amylase gene, Amy-1, in the parotid gland and the liver. Cell 1983;33:501-508.
34. McKnight GS, Palmiter RD. Transcriptional regulation of the ovalbumin and conalbumin genes by steroid hormones in chick oviduct. J Biol Chem 1979;254:9050-9058.
35. Greenberg ME, Ziff EB. Stimulation of 3T3 cells induces transcription of the c-fos protooncogene. Nature 1984;311:433-438.
36. Burton K. A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1956;65:315-323.
37. Sikorska M, Brewer LM, Youdale T, et al. Evidence that mammalian ribonucleotide reductase is a nuclear membrane associated glycoprotein. Biochem Cell Biol 1990;68:880-888.
38. Manjeshwar S, Backway KL, Rao PM, Rajalakshmi S, Sarma DSR. Effect of actinomycin D on the accumulation of uridine nucleotides by orotic acid, a rat liver tumor promoter. Abstract. Proceedings of the American Association for Cancer Research 1994;35:580.
39. Hentze MW. Determinants and regulation of cytoplasmic mRNA stability in eukaryotic cells. Biochim Biophys Acta 1991; 1090:281-292.
40. Brewer G. An A+U rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol Cell Biol 1991;11:2450-2466.
41. Shyu AB, Greenberg ME, Belasco JG. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev 1989;3:60-72.
42. Rabbits PH, Foster A, Stenson MA, Rabbits TH. Truncation of exon-1 from the c-myc gene results in prolonged c-myc mRNA stability. EMBO J 1985;4:3727-3733.
43. Chen FY, Amara FM, Wright JA. Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbolester stimulating conditions: involvement of a cis-trans interaction of the 3′ untranslated region. EMBO J 1993;12:3977-3986.
44. Amara FM, Chen FY, Wright JA. Defining a novel cis-element in the 3′ untranslated region of mammalian ribonucleotide reductase component R2 mRNA: Cis-trans actions and message stability. J Biol Chem 1996;271:20126-20131.
45. Eriksson S, Gudas LJ, Clift SM, Caras IW, Ullman B, Martin DW. Evidence for genetically independent allosteric regulatory domains of the protein M1 subunit of mouse ribonucleotide reductase. J Biol Chem 1981;256:10193-10197.
46. Weinberg G, Ullman B, Martin DW. Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools. Proc Natl Acad Sci USA 1981;78:2447-2451.
47. Laniken H, Graslund A, Theilander L. Induction of a new ribonucleotide reductase after infection of mouse cells with pseudorabies virus. J Virol 1982;14:893-900.
48. Avarett DR, Lubberg C, Elion GB, Spector T. Ribonucleotide reductase induced by herpes simplex type 1 virus: characterization of a distinct enzyme. J Biol Chem 1983;258:9831-9838.
49. Cohen GH. Ribonucleotide reductase activity of synchronized KB cells infected with herpes simplex. J Virol 1972;9:408-418.
50. Cohen GH. Inhibition of herpex simplex virus type 2 replication by thymidine. J Virol 1974;14:20-25.
51. Amara FM, Hurta RAR, Huang A, Wright JA. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNA in hydroxyurea resistant cells. Cancer Res1995; 55:4503-4506.
52. Fan H, Christy V, Wright JA. Ribonucleotide reductase R2 component is a novel malignancy determinant that co-operates with activated oncogenes to determine transformation and malignant potential. Proc Natl Acad Sci USA 1996;93:14036-14040.
53. Manjeshwar S, Laconi E, Rao PM, Rajalakshmi S, Sarma DSR. Influence of orotic acid on multistage hepatocarcinogenesis in the rat: Resistance of hepatocytes from nodules to mitoinhibitory effects of orotic acid. Proc Soc Exp Biol Med 1993;202:25-29.
54. Lea MA, Oliphant V, Luke A, Tesoriero JV. Uptake and metabolism of orotate in normal and neoplastic tissues. Abstract. Proceedings of the American Association for Cancer Research 1986;27:18.
55. Hartleib M, Lee G, Farber E. Ribonucleotide reductase, a target for the mitoinhibitory effects of 2-acetylaminoflorene during promotion. Abstract. Proceedings of the American Association for Cancer Research 1994;35:168.